关税，突变！白宫最新发声！

Group 1: Core Views - The recent U.S. tariff policy changes will not apply to countries that have trade agreements with the U.S., such as the EU and Japan, which will maintain a 15% tariff cap on pharmaceuticals [2][4] - President Trump announced a 100% tariff on all brand-name and patented drugs starting October 1, 2025, unless companies establish manufacturing in the U.S. [4][5] - The U.S. Chamber of Commerce has urged the government to reconsider new tariffs on heavy trucks, emphasizing that major import sources are allies and do not pose a security threat [6] Group 2: Market Reactions - Following the announcement of the new tariffs, pharmaceutical stocks showed mixed performance in the U.S. market, with Novavax rising by 2.52% and Moderna falling by 0.49% [1] - Japanese and South Korean pharmaceutical stocks mostly declined, with notable drops including Sumitomo Pharma down over 3% and Samsung Biologics down over 2% [1] Group 3: Impact on Other Industries - The Canadian steel industry has faced significant declines due to U.S. tariffs, with production down 24.8% and exports down 25.5% since March [7] - The U.S. Labor Statistics Bureau reported a 4.7% year-over-year increase in furniture prices due to tariff impacts [5]